Are you Dr. Shapira?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 28 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4015 S Cobb Dr Se
Suite 245
Smyrna, GA 30080Phone+1 770-333-0093Fax+1 770-432-2643
Summary
- Dr. Nathan Shapira, MD is a board certified psychiatrist in Smyrna, Georgia. He is currently licensed to practice medicine in Georgia, Florida, and Ohio.
Education & Training
University of Cincinnati Medical Center/College of MedicineResidency, Psychiatry, 1995 - 1999
Vanderbilt University School of MedicineClass of 1995
Certifications & Licensure
GA State Medical License 2006 - 2026
OH State Medical License 1996 - 2014
FL State Medical License 1999 - 2013- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome Start of enrollment: 2002 Jul 01
- Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression Start of enrollment: 2010 Nov 01
- Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder Start of enrollment: 2011 Jan 01
Publications & Presentations
PubMed
- 79 citationsDetecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics.Tanya K. Murphy, Muhammad Sajid, Ohel Soto, Nathan A. Shapira, Paula J. Edge
Biological Psychiatry. 2004-01-01 - 59 citationsOpen‐label pilot study of tramadol hydrochloride in treatment‐refractory obsessive‐compulsive disorderNathan A. Shapira, Paul E. Keck, Toby D. Goldsmith, Brian J. McConville, Michael J. Eis
Depression and Anxiety. 1997-01-01 - 45 citationsRapid remission of OCD with tramadol hydrochloride.Toby D. Goldsmith, Nathan A. Shapira, Paul E. Keck
The American Journal of Psychiatry. 1999-04-01
